Understanding how immunosuppression affects breast cancer in Hispanic/Latino patients
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
['FUNDING_OTHER'] · UNIVERSITY OF SOUTHERN CALIFORNIA · NIH-10879651
This study is looking at how biological differences might affect breast cancer treatment outcomes for Hispanic and Latino patients, using blood and tissue samples to better understand their unique responses to therapy, with the goal of improving treatment options for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTHERN CALIFORNIA (nih funded) |
| Locations | 1 site (Los Angeles, UNITED STATES) |
| Trial ID | NIH-10879651 on ClinicalTrials.gov |
What this research studies
This research investigates the biological factors that contribute to disparities in breast cancer outcomes among Hispanic/Latino patients. By analyzing blood samples and breast tissue, the study aims to understand how the tumor microenvironment affects immune responses to treatment. The project combines demographic and clinical data with advanced multi-omics techniques to uncover the mechanisms of resistance to immunotherapy. This research seeks to improve the representation of minority groups in clinical trials and enhance treatment strategies tailored to their unique biological responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic/Latino patients diagnosed with breast cancer who are 21 years or older.
Not a fit: Patients who do not identify as Hispanic/Latino or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for Hispanic/Latino patients with breast cancer.
How similar studies have performed: Other research has shown success in addressing disparities in cancer treatment through targeted studies, but this specific focus on Hispanic/Latino patients and immunosuppression is relatively novel.
Where this research is happening
Los Angeles, UNITED STATES
- UNIVERSITY OF SOUTHERN CALIFORNIA — Los Angeles, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROUSSOS TORRES, EVANTHIA THEODOSIOU — UNIVERSITY OF SOUTHERN CALIFORNIA
- Study coordinator: ROUSSOS TORRES, EVANTHIA THEODOSIOU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.